Merck

Merck Serono, Auxogyn collaborate on Eeva Test

Friday, October 19, 2012 11:01 AM

Merck Serono, the biopharmaceutical division of Merck, and Auxogyn, a company focused on translating scientific discoveries in early embryo development into clinical tools, have entered into a strategic agreement focused on Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test.

More... »

Merck Serono: 40% of Geneva staff have job prospects

Tuesday, October 2, 2012 01:50 PM

Merck Serono has provided an update on the redeployment of its Geneva-based staff, 100 days after announcing its decision to close the site. As of Sept. 28, job prospects have been clarified for more than 500 employees, or 40% of Geneva-based employees:

More... »

EMD Millipore opens GMP bioproduction facility in France

Tuesday, September 25, 2012 12:02 PM

EMD Millipore, the Billerica, Mass.-based life science division of Merck, has opened its advanced GMP bioproduction facility in Martillac, France, offering a full, single-use process train to speed a molecule’s journey to the clinic.

More... »

AMRI promotes Daniel Conlon to senior director of business development

Friday, September 14, 2012 12:51 PM

AMRI, a global contract research and manufacturing organization, has promoted Daniel Conlon to senior director of business development.

More... »

Abbott, Astellas collaborate on CMV vaccine trial

Monday, September 10, 2012 11:03 AM

Abbott has signed an agreement to collaborate with Astellas Pharma Global Development in a phase III clinical trial for ASP0113 (TransVax), an investigational vaccine licensed from Vical for preventing cytomegalovirus (CMV) reactivation in transplant patients.

More... »

Merck, employee representatives agree on efficiency plan for Germany

Wednesday, September 5, 2012 10:47 AM

Merck, a global healthcare company based in Darmstadt, Germany, has signed an agreement with employee representatives on an efficiency plan for the company's Germany operations.

More... »

Merck Serono spin-off Quartz Bio to offer biomarker data analysis

Tuesday, September 4, 2012 12:41 PM

Merck Serono, a division of Merck, has created Quartz Bio, the second spin-off company resulting from its Entrepreneur Partnership Program launched in April. Quartz Bio will offer biomarker data management and exploratory biomarker analysis services to the pharmaceutical industry. Biomarker analysis is a critical step in the drug development process, as it enables the identification of patient profiles most responsive to a given treatment.

More... »

EMD Millipore to acquire Biochrom

Thursday, August 23, 2012 09:54 AM

EMD Millipore, the life science division of Merck of Darmstadt, Germany, has decided to acquire Biochrom, a cell culture media specialist of Berlin, Germany. The closing price was not disclosed.

More... »

Ark Therapeutics signs a letter of intent with EMD Millipore

Friday, August 17, 2012 11:13 AM

Ark Therapeutics, a London-based contract development and manufacturing company focused on viral product, has signed a non-binding letter of intent with EMD Millipore, a division of Merck, to enter into a collaborative agreement in the field of viral based bioengineered vaccines and other live viral products manufacturing. 

More... »

PatientsLikeMe, Merck collaborate on evaluating psoriasis impact

Friday, August 17, 2012 09:23 AM

PatientsLikeMe, a social networking health site, has entered into a collaboration with global pharmaceutical company Merck to evaluate the impact of psoriasis on patients and to inform a novel approach to improving outcomes.

More... »